Cinclus Pharma participates at RedEye Investor Forum in Gothenburg
Christer Ahlberg, CEO of Cinclus Pharma, will participate at Redeye Investor Forum in Gothenburg October 9th.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Improving the quality of life for more people
Highlights from the 2024 Annual Report: Sustainability. Driving the development of medicines that can alleviate and cure globally prevalent diseases is Cinclus Pharma’s main contribution to improved public health and social sustainability.
Read more
Biotech TV interviews Christer Ahlberg
Interview with Cinclus Pharma’s CEO Christer Ahlberg on Biotech TV at the Pareto Healthcare Conference in Stockholm.
Read more